Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30000264
Basic Information
VIS ID
TVIS30000264
Fusion event
HIV-RABGAP1L integration
Validated
No
Detection method
NG-SGS
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2018
PubMed ID
30024859
Virus Sequence
Virus name
HIV
Reference genome
K03455.1
Host Sequence
Chromosome
chr1
Cytoband
q25.1
Reference genome
GRCh37/hg19
Start
174180673/174211535 (Hg38)
End
174180673/174211535 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA1G
Target gene
RABGAP1L
miRNAs that regulate target gene
hsa-mir-1-3p
;
hsa-mir-4504
;
hsa-mir-4778-3p
;
hsa-mir-676-5p
;
hsa-mir-4714-3p
;
hsa-mir-34c-3p
;
hsa-mir-7161-3p
;
hsa-mir-3156-5p
;
hsa-mir-6848-3p
;
hsa-mir-6843-3p
;
hsa-mir-3187-3p
;
hsa-mir-4435
;
hsa-mir-588
;
hsa-mir-4701-5p
;
hsa-mir-548s
;
hsa-mir-378a-5p
;
hsa-mir-6802-5p
;
hsa-mir-6800-5p
;
hsa-mir-6131
;
hsa-mir-4755-3p
;
hsa-mir-6759-3p
;
hsa-mir-3663-5p
;
hsa-mir-3653-5p
;
hsa-mir-372-5p
;
hsa-mir-371a-5p
;
hsa-mir-616-5p
;
hsa-mir-373-5p
;
hsa-mir-371b-5p
;
hsa-mir-4781-3p
;
hsa-mir-5089-5p
;
hsa-mir-6807-5p
;
hsa-mir-5589-5p
;
hsa-mir-4731-5p
;
hsa-mir-6778-3p
;
hsa-mir-6506-5p
;
hsa-mir-619-5p
;
hsa-mir-150-5p
;
hsa-mir-1224-3p
;
hsa-mir-186-3p
;
hsa-mir-520h
;
hsa-mir-520g-3p
;
hsa-mir-6504-3p
;
hsa-mir-512-3p
;
hsa-mir-576-3p
;
hsa-mir-520e
;
hsa-mir-520d-3p
;
hsa-mir-520c-3p
;
hsa-mir-520b
;
hsa-mir-520a-3p
;
hsa-mir-373-3p
;
hsa-mir-372-3p
;
hsa-mir-302e
;
hsa-mir-302d-3p
;
hsa-mir-302c-3p
;
hsa-mir-302b-3p
;
hsa-mir-302a-3p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-106b-5p
;
hsa-mir-106a-5p
;
hsa-mir-1297
;
hsa-mir-1343-3p
;
hsa-mir-1976
;
hsa-mir-23a-5p
;
hsa-mir-23b-5p
;
hsa-mir-26a-5p
;
hsa-mir-26b-5p
;
hsa-mir-4279
;
hsa-mir-4465
;
hsa-mir-4722-3p
;
hsa-mir-4740-3p
;
hsa-mir-6513-3p
;
hsa-mir-660-3p
;
hsa-mir-6727-3p
;
hsa-mir-6742-3p
;
hsa-mir-6747-3p
;
hsa-mir-6783-3p
;
hsa-mir-6791-3p
;
hsa-mir-6829-3p
;
hsa-mir-6836-3p
;
hsa-mir-6852-5p
;
hsa-mir-8062
;
hsa-mir-939-3p
Nearest miRNA
hsa-mir-101-1/Upstream/2066891; hsa-mir-1182/Downstream/1756835;
Nearest TSS
ENST00000473358/Upstream/51531;
ENST00000487987/Downstream/9177;
Nearest CpG islands
None/Target,
chr1-CpG: 111/Upstream/51626
,
chr1-CpG: 121/Downstream/787818
Upstream sequence
caagatagtatttgcaagactcattgtaaccttaaatctaaaaacatacaataagtacaaaaaaattgagaagcaagaaattaaatcatgccatcataga
Downstream sequence
aaatcaccttgactaaaaggatgacagaaaggaaagaaggaagcaaataccagaaaacaagtaacagttataggagtaagtccttacttatcagcaataa
Reference
Sharaf, R., et al.HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest,2018,128(9): 4074-4085.
Sample Information
×
Sample name
1C104
Sample type
PBMC
Age
41
Gender
Male
CpG Island Information
×
Download
Curate